
Fressia Pharmaceuticals Private Limited
About Fressia Pharmaceuticals Private Limited
Data last updated:
Fressia Pharmaceuticals Private Limited is a private limited company based in Dholpur, Rajasthan, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 24 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2015PTC047945. Its GSTIN is 08AACCF6185A1ZT (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Upadhyay and Raj Tyagi Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ummedi Nagar Near Rajakhera Bypass, Dholpur, Rajasthan, India – 328001.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.17 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net loss of ₹865 (net margin -0.2%) and EBITDA of ₹68 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fressia Pharmaceuticals Private Limited's registered office is in Dholpur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUmmedi Nagar Near Rajakhera Bypass, Dholpur, Rajasthan, India – 328001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Fressia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fressia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fressia Pharmaceuticals Private Limited, buy the company report.
Financials of Fressia Pharmaceuticals Private Limited
FY 2025 filings availableFressia Pharmaceuticals Private Limited reported revenue of ₹4.17 Lakh (up 52% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 52% growth in the latest year. EBITDA fell 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹68 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹865 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fressia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fressia Pharmaceuticals Private Limited
Fressia Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Upadhyay | Director | 24 Jul 2015 | 11 Years 3 Months | Current |
| Raj Tyagi Kumar | Director | 24 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Fressia Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Smark Pharmaceuticals Private Limited | ₹4.23 Lakh (FY 2025) | -2.0% | Uttar Pradesh, India | |||
| Rabindra Pharmaceuticals Private Limited | ₹4.22 Lakh (FY 2025) | -60.0% | Muzaffarpur, Bihar, India | |||
| Fressia Pharmaceuticals Private Limitedthis company | ₹4.17 Lakh (FY 2025) | -₹865 | -0.2% | 52.0% | Dholpur, Rajasthan, India | |
| Winsun Pharmaceuticals Private Limited | ₹4.16 Lakh (FY 2018) | 8.0% | Patna, Bihar, India | |||
| Steeford Pharmaceuticals Private Limited | ₹4.16 Lakh (FY 2025) | 14.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Fressia Pharmaceuticals Private Limited, buy the company report.
Auditor
Fressia Pharmaceuticals Private Limited is audited by SANKALP PITALIYA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANKALP PITALIYA & ASSOCIATES | FY 2017 | 534674 |
Shareholding
The shareholding of Fressia Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Fressia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fressia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fressia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fressia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCF6185A1ZT | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fressia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fressia Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Amit Upadhyay was appointed as Director on 24 Jul 2015.
Frequently asked questions
Fressia Pharmaceuticals is an active private limited company based in Dholpur, Rajasthan, India. The company works in other wholesale, within the trading industry. It was incorporated on 24 July 2015 (11+ years old) and is registered under CIN U24232RJ2015PTC047945.
Fressia Pharmaceuticals has 2 current directors:
- Amit Upadhyay - Director
- Raj Tyagi Kumar - Director
The latest financial statements of Fressia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Fressia Pharmaceuticals is 08AACCF6185A1ZT, registered in Rajasthan.
The CIN (Corporate Identification Number) of Fressia Pharmaceuticals is U24232RJ2015PTC047945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fressia Pharmaceuticals was incorporated on 24 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Fressia Pharmaceuticals by revenue are Smark Pharmaceuticals Private Limited, Rabindra Pharmaceuticals Private Limited, Winsun Pharmaceuticals Private Limited, Steeford Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Upadhyay was appointed as Director on 24 Jul 2015. Raj Tyagi Kumar was appointed as Director on 24 Jul 2015.
The registered office of Fressia Pharmaceuticals is at Ummedi Nagar Near Rajakhera Bypass, Dholpur, Rajasthan, India – 328001.
Fressia Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Fressia Pharmaceuticals is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.

